Toxicidad
Cabozantinib
(n=331)
Everolimus
(n=322)
Median duration of
exposure, months
8.3
4.4
Median average daily dose
43 mg
9 mg
Any dose reduction, % (n)
62 (206)
25 (80)
Discontinued due to adverse
event not associated with
RCC, % (n)
12 (40)
11 (34)
